市场调查报告书
商品编码
1451402
按测试类型(TSH 测试、T3 测试、T4 测试等)、适应症(甲状腺功能减退症、甲状腺功能亢进、甲状腺癌等)、最终用户(医院、诊断实验室等)和地区分類的甲状腺功能测试市场报告2024 -2032Thyroid Function Test Market Report by Test Type (TSH Tests, T3 Tests, T4 Tests, and Others), Indication (Hypothyroidism, Hyperthyroidism, Thyroid Cancer, and Others), End User (Hospitals, Diagnostic Laboratories, and Others), and Region 2024-2032 |
2023年全球甲状腺功能检测市场规模达16亿美元。展望未来, IMARC Group预计到2032年市场规模将达到26亿美元,2024-2032年复合年增长率(CAGR)为5.1%。
甲状腺功能测试用于测量血液中激素的水平。他们帮助医疗保健专业人员诊断甲状腺炎、结节、癌症、肿瘤、甲状腺肿、格雷夫斯病、桥本病、甲状腺功能亢进症和甲状腺功能减退症等疾病。医生建议评估甲状腺功能的一些测试包括三碘甲状腺原氨酸 (T3)、甲状腺素 (T4)、降钙素、甲状腺球蛋白、甲状腺抗体和促甲状腺激素 (TSH)。目前,促甲状腺素受体自体抗体(TRAb)升高的婴儿数量不断增加,骨龄提前,颅缝早闭等甲状腺相关疾病的风险很高。因此,对甲状腺功能测试的需求增加,以筛检新生儿是否有甲状腺遗传问题。
某些药物(例如胺碘酮和锂)以及第 1 型糖尿病、乳糜泻、艾迪生氏症、唐氏症和特纳氏症等疾病会增加甲状腺的风险。这与大量的医疗疾病和容易获得的医疗服务相结合,是积极影响甲状腺功能测试需求的重要因素之一。此外,甲状腺激素维持大脑、心臟、肌肉和其他器官的功能,其分泌不足或过多会导致严重的健康恶化。随着人们对早期诊断的认识不断提高和诊断方式的改进,这一点正在促进市场的成长。除此之外,不断增长的老年人口以及许多国家卫生机构支持的大量宣传活动正在推动甲状腺功能测试市场的发展。此外,由于婴儿先天性疾病盛行率不断上升,各国政府正计划强制实施新生儿筛检计画。再加上父母对孩子健康的日益关注,正在推动市场的成长。
The global thyroid function test market size reached US$ 1.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032.
Thyroid function tests are used to measure the levels of hormones in the blood. They help healthcare professionals diagnose diseases like thyroiditis, nodules, cancer, tumors, goiter, Graves', Hashimoto's, hyperthyroidism, and hypothyroidism. Some of the tests advised by doctors to evaluate thyroid function include triiodothyronine (T3), thyroxine (T4), calcitonin, thyroglobulin, thyroid antibody, and thyroid-stimulating hormone (TSH). Presently, there is a rise number of infants with elevated thyrotropin receptor autoantibodies (TRAb), advanced bone age, and craniosynostosis are at a high risk of developing thyroid-related conditions. As a result, there is an increase in the demand for thyroid function tests to screen newborn babies for inherited problems with the thyroid gland.
Certain medications, such as amiodarone and lithium, and conditions like Type 1 diabetes, Coeliac, Addison's, Down's, and Turner syndrome increase the risk of developing thyroid. This, in confluence with a plethora of medical ailments and easy access to healthcare services, represents one of the significant factors positively influencing the need for thyroid function tests. Moreover, thyroid hormones maintain the functions of the brain, heart, muscles, and other organs and their under or overproduction can lead to serious health deteriorations. This, along with the increasing awareness about early diagnosis and improving diagnostic modalities, is contributing to market growth. Besides this, the growing geriatric population and considerable number of awareness campaigns supported by health agencies of numerous countries are driving the market for thyroid function tests. Furthermore, governments of various countries are planning to mandate newborn screening programs due to the rising prevalence of congenital conditions among infants. This, coupled with the increasing concerns among parents about the health of their children, is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global thyroid function test market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on test type, indication and end user.
TSH Tests
T3 Tests
T4 Tests
Others
Hypothyroidism
Hyperthyroidism
Thyroid Cancer
Others
Hospitals
Diagnostic Laboratories
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Autobio Diagnostics Co. Ltd, bioMerieux SA, Diagnostic Automation/Cortez Diagnostics Inc., DiaSorin S.p.A., F. Hoffmann-La Roche AG, Merck KGaA, Qualigen Inc., Quidel Corporation, Siemens AG, and Thermo Fisher Scientific Inc.